Drug discovery is a challenging endeavor with a high failure rate. This is further complicated by the fact that each disease has its own unique set of obstacles to developing a safe and effective therapy. Flexible and robust analytical methods are critical for efficiently solving these issues, where nuclear magnetic resonance (NMR) plays an important role in nearly every stage of the drug discovery process. This review will highlight recent developments in the application of NMR as a screening tool for drug discovery that includes: library design, various ligand-affinity screening techniques, rapid determination of protein-ligand co-structures, and the functional annotation of proteins to the discovery of new therapeutic targets.
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
Tel.: +1 703 830 6300
Fax: +1 703 830 2300 email@example.com
(Corporate matters and books only) IOS Press c/o Accucoms US, Inc.
For North America Sales and Customer Service
West Point Commons
Lansdale PA 19446
Tel.: +1 866 855 8967
Fax: +1 215 660 5042 firstname.lastname@example.org